KH Medical Expands Reagent Lineup for Multi-Channel Immunofluorescence Analyzer TTAni-F

KH Medical announced that it is continuously expanding the reagent lineup for its multi-channel immunofluorescence diagnostic system, TTAni-F, used in veterinary diagnostics. With the addition of various test parameters for companion animal diagnostics, the company aims to establish an integrated diagnostic environment that enables in-clinic testing, including thyroid function tests and quantitative antibody analysis.

Most in vitro diagnostic systems are designed to perform a single test at a time, requiring each test to be completed before initiating the next. In contrast, the TTAni-F system adopts a multi-channel structure capable of performing up to four tests simultaneously, providing enhanced operational efficiency for veterinary clinics handling high test volumes or multiple diagnostic parameters.

Currently, the TTAni-F system supports a wide range of key diagnostic reagents, including CRP, SAA, cPL, fPL, SDMA, T4, Cortisol, and NT-proBNP, covering inflammation, pancreatic, renal, hormonal, and cardiac conditions. In addition, new reagents such as cTSH and Free T4, essential for thyroid function assessment, are expected to be introduced.

Hormone diagnostics require highly sensitive analysis due to the need to detect trace-level concentrations and have traditionally relied on expensive, large-scale equipment. However, TTAni-F utilizes Europium-based fluorescence detection technology, enabling precise quantitative analysis of minute hormone levels. This is expected to allow veterinary clinics to perform rapid and accurate thyroid function tests in-house.

Furthermore, the system is expanding its capabilities in antibody testing used to assess immune responses following vaccination in companion animals. While conventional in-clinic antibody tests have been limited to semi-quantitative methods, the upcoming TTAni-F antibody reagents will support quantitative antibody titer analysis, enabling more precise evaluation of immune status.

A representative of KH Medical stated,
“We will continue to introduce new diagnostic reagents to ensure faster and more accurate testing within veterinary clinics.”

Launched in February 2025, the TTAni-F system has been rapidly adopted, with installations in hundreds of veterinary clinics nationwide within its first year. For inquiries regarding the system and its reagents, customers can contact KH Medical directly, with official domestic distributors including Anda Co., Ltd. and Doif Co., Ltd.

Meanwhile, KH Medical has been providing integrated diagnostic solutions across clinical diagnostics, veterinary diagnostics, and point-of-care testing (POCT), supported by its R&D-driven technological capabilities and internationally compliant quality management system. As demand for immunofluorescence-based diagnostic technologies continues to grow alongside the expansion of the companion animal market, the company is further strengthening its global diagnostic product portfolio.

In addition, KH Medical plans to further accelerate its global market expansion by participating in WHX 2026 (World Health Expo Dubai 2026), the world’s largest medical device exhibition.
The event will be held in Dubai, UAE, from February 10 to 13 (local time). Through this exhibition, KH Medical aims to showcase its immunodiagnostic and molecular diagnostic platforms while actively engaging in the development of new overseas buyers and expanding global partnerships.

Source: E2 News
http://www.e2news.com